Evidence map›Paper›PMID 29799631›Full record

ArticleBiomedical chromatography : BMC2018

Metabolic alterations in triptolide-induced acute hepatotoxicity.

Jie Zhao, Cen Xie, Xiyan Mu, Kristopher W Krausz, Daxesh P Patel, Xiaowei Shi, Xiaoxia Gao, Qiao Wang, Frank J Gonzalez

Open access · greenAbstract read
In one paragraph

Article in Biomedical chromatography : BMC, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
4.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Jie ZhaoHebei Medical University, School of Pharmaceutical Science, Shijiazhuang, Hebei, China.
Cen XieNational Cancer Institute, National Institutes of Health, Laboratory of Metabolism, Center for Cancer Research, Bethesda, Maryland, USA.
Xiyan MuHebei Medical University, School of Pharmaceutical Science, Shijiazhuang, Hebei, China.
Kristopher W KrauszNational Cancer Institute, National Institutes of Health, Laboratory of Metabolism, Center for Cancer Research, Bethesda, Maryland, USA.
Daxesh P PatelNational Cancer Institute, National Institutes of Health, Laboratory of Metabolism, Center for Cancer Research, Bethesda, Maryland, USA.
Xiaowei ShiHebei Medical University, School of Pharmaceutical Science, Shijiazhuang, Hebei, China.
Xiaoxia GaoNational Cancer Institute, National Institutes of Health, Laboratory of Metabolism, Center for Cancer Research, Bethesda, Maryland, USA.
Qiao WangHebei Medical University, School of Pharmaceutical Science, Shijiazhuang, Hebei, China.ORCID http://orcid.org/0000-0003-4693-2332
Frank J GonzalezNational Cancer Institute, National Institutes of Health, Laboratory of Metabolism, Center for Cancer Research, Bethesda, Maryland, USA.
National Institutes of Health · USHebei Medical University · CN

Funding

Xenobiotic ReceptorsZIABC005708 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI GONZALEZ, FRANK J · 2009 to 2025
$16.4M
Hebei Science and Technology Department in China 17392501DIntramural NIH HHS Z99 CA999999
6 · The paper itself

Abstract

Triptolide, a major active constitute of Tripterygium wilfordii Hook. F, is prescribed for the treatment of autoimmune diseases in China. One of its most severe adverse effects observed in the clinical use is hepatotoxicity, but the mechanism is still unknown. Therefore, the present study applied an LC/MS-based metabolomic analysis to characterize the metabolomic changes in serum and liver induced by triptolide in mice. Mice were administered triptolide by gavage to establish the acute liver injury model, and serum biochemical and liver histological analyses were applied to assess the degree of toxicity. Multivariate data analyses were performed to investigate the metabolic alterations. Potential metabolites were identified using variable importance in the projection values and Student's t-test. A total of 30 metabolites were observed that were significantly changed by triptolide treatment and the abundance of 29 metabolites was correlated with the severity of toxicity. Pathway analysis indicated that the mechanism of triptolide-induced hepatotoxicity was related to alterations in multiple metabolic pathways, including glutathione metabolism, tricarboxylic acid cycle, purine metabolism, glycerophospholipid metabolism, taurine and hypotaurine metabolism, pantothenate and CoA biosynthesis, pyrimidine metabolism and amino acid metabolism. The current study provides new mechanistic insights into the metabolic alterations that lead to triptolide-induced hepatotoxicity.

Indexed as

AnimalsChemical and Drug Induced Liver InjuryChromatography, High Pressure LiquidChromatography, LiquidDiterpenesEpoxy CompoundsLiverMaleMetabolomeMetabolomicsMiceMice, Inbred C57BLPhenanthrenesSpectrometry, Mass, Electrospray IonizationDiterpenesEpoxy CompoundsPhenanthrenestriptolidehepatotoxicityHILICmetabolomicstriptolideUPLC-ESI-QTOFMS

Identifiers

PMID29799631
PMCPMC6150827
OpenAlexW2803757858

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.